Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Cancer Res ; 60(11): 2780-5, 2000 Jun 01.
Article in English | MEDLINE | ID: mdl-10850413

ABSTRACT

Hemizygous deletions of the fragile histidine triad (FHIT) gene at human chromosome band 3p14.2 and down-regulation of its gene product are found in the majority of renal cell carcinomas (RCCs). Functional tumor suppressive activity of Fhit in renal cancer cells previously was observed in RCC cell line RC48, which lacks endogenous Fhit expression. To further investigate the potential role of FHIT as a tumor suppressor gene in RCC, we transfected FHIT cDNA expression constructs into RCC cell lines RCC-1 and SN12C, which show low-level expression of endogenous Fhit and reveal an intact von Hippel-Lindau (VHL) gene. Stable transfectants of both cell lines showed no alterations of cell morphology, proliferation kinetics, or cell cycle parameters in vitro. The FHIT gene transfer rate, however, was significantly lower in RCC-1 cells compared with SN12C cells, suggesting a selection against exogenous Fhit expression. In addition, in nude mouse assays, a significant delay of tumor formation was observed for FHIT-transfected RCC-1 cell lines, with outgrowing tumors demonstrating loss of Fhit expression in the majority of cells. In contrast, tumorigenicity of FHIT-transfected SN12C cell clones was not suppressed, despite stable transgene expression. In conclusion, our results demonstrate a selective tumor suppressive activity of Fhit in RCC cells in vivo and suggest that the susceptibility to suppression is not restricted to cancer cells with complete loss of Fhit expression.


Subject(s)
Acid Anhydride Hydrolases , Carcinoma, Renal Cell/genetics , Kidney Neoplasms/genetics , Neoplasm Proteins , Proteins/genetics , Proteins/metabolism , Suppression, Genetic , Animals , Blotting, Western , Cell Cycle/genetics , Chromosomes, Human, Pair 3 , DNA, Complementary/metabolism , Down-Regulation , Fluorescent Antibody Technique , Humans , Immunohistochemistry , Mice , Mice, Nude , Neoplasm Transplantation , Transfection , Tumor Cells, Cultured
2.
Cell Biol Int ; 23(1): 73-80, 1999.
Article in English | MEDLINE | ID: mdl-10527549

ABSTRACT

Endothelial cells can reversibly be forced to suppress the formation of endothelial junctions (EJ) by cultivation in a low calcium medium. The authors localized vinculin and cadherin as marker proteins of EJ and actin as a cytoskeletal component by fluorescence microscopy, and used this cell model to study the reformation of endothelial junctions under conditions of activation and inhibition of protein kinase C (PKC). Inhibition of PKC by H-7 leads to an acceleration of EJ reformation, while constitutive activation by TPA inhibits the reformation process.


Subject(s)
Endothelium, Vascular/cytology , Endothelium, Vascular/physiology , Intercellular Junctions/physiology , Protein Kinase C/physiology , 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine/pharmacology , Animals , Cadherins/physiology , Cell Line , Enzyme Activation/physiology , Enzyme Inhibitors/pharmacology , Phorbol Esters/pharmacology , Signal Transduction , Vinculin/physiology , Xenopus
SELECTION OF CITATIONS
SEARCH DETAIL
...